Literature DB >> 27542398

Asbestos exposure and histological subtype of malignant mesothelioma.

P Franklin1, H Alfonso2, A Reid2, N Olsen1, K B Shilkin3, F Brims4, N de Klerk5, A W Musk4.   

Abstract

BACKGROUND: Malignant mesothelioma (MM) has distinct histological subtypes (epithelioid, sarcomatoid and biphasic) with variable behaviour and prognoses. It is well recognised that survival time varies with the histological subtype of MM. It is not known, however, if asbestos exposure characteristics (type of asbestos, degree of exposure) are associated with different histological subtypes. AIM: To determine if the pathological MM subtype is associated with the type of asbestos or the attributes of asbestos exposure.
METHODS: Cases of MM for the period 1962 until 2012, their main histological subtype and their most significant source of asbestos exposure were collected from the Western Australian Mesothelioma Registry. Exposure characteristics included, degree of asbestos exposure (including total days exposed, years since first exposure and, for crocidolite only, calculated cumulative exposure), source of exposure (occupational or environmental), form of asbestos handled (raw or processed) and type of asbestos (crocidolite only or mixed fibres).
RESULTS: Patients with the biphasic subtype were more likely to have occupational exposure (OR 1.83, 1.12 to 2.85) and exposure to raw fibres (OR 1.58, 1.19 to 2.10). However, differences between subtypes in the proportions with these different exposure characteristics were small and unlikely to be biologically relevant. Other indicators of asbestos exposure were not associated with the histological subtype of mesothelioma.
CONCLUSIONS: There was no strong evidence of a consistent role of asbestos exposure indicators in determining the histological subtype of MM. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  exposure

Mesh:

Substances:

Year:  2016        PMID: 27542398     DOI: 10.1136/oemed-2016-103721

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  2 in total

1.  Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.

Authors:  Sanjeevan Muruganandan; Helman Alfonso; Peter Franklin; Keith Shilkin; Amanda Segal; Nola Olsen; Alison Reid; Nick de Klerk; Aw Bill Musk; Fraser Brims
Journal:  Br J Cancer       Date:  2017-02-14       Impact factor: 7.640

2.  Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.

Authors:  Caterina Ledda; Paola Senia; Venerando Rapisarda
Journal:  Cancers (Basel)       Date:  2018-06-15       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.